{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:07:39Z","timestamp":1780340859082,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004351","name":"Sultan Qaboos University","doi-asserted-by":"publisher","award":["IG\/MED\/PHAR\/17\/1"],"award-info":[{"award-number":["IG\/MED\/PHAR\/17\/1"]}],"id":[{"id":"10.13039\/501100004351","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.biopha.2017.10.107","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T05:19:48Z","timestamp":1510291188000},"page":"1102-1108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on gentamicin nephrotoxicity in mice"],"prefix":"10.1016","volume":"97","author":[{"given":"Yousuf M.","family":"Al Suleimani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aly M.","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turan","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyadarsini","family":"Manoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Ashique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abderrahim","family":"Nemmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badreldin H.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biopha.2017.10.107_bib0005","doi-asserted-by":"crossref","first-page":"724","DOI":"10.5694\/j.1326-5377.1992.tb121517.x","article-title":"Drug-induced renal disease","volume":"156","author":"Mathew","year":"1992","journal-title":"Med. J. Aust."},{"issue":"2","key":"10.1016\/j.biopha.2017.10.107_bib0010","first-page":"284","article-title":"Aminoglycoside nephrotoxicity in humans","volume":"5","author":"Lietman","year":"1983","journal-title":"J. Infect. Dis."},{"issue":"9\u201310","key":"10.1016\/j.biopha.2017.10.107_bib0015","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.lfs.2007.11.014","article-title":"Time dependent effects of gentamicin on the enzymes of carbohydrate metabolism, brush border membrane and oxidative stress in rat kidney tissues","volume":"82","author":"Banday","year":"2008","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.107_bib0020","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1128\/AAC.16.4.468","article-title":"Urinary casts as an indicator of renal tubular damage in patients receiving aminoglycosides","volume":"16","author":"Schentag","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.107_bib0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1172\/JCI111184","article-title":"Calcium is a competitive inhibitor of gentamicin-renal membrane binding interactions and dietary calcium supplementation protects against gentamicin nephrotoxicity","volume":"73","author":"Humes","year":"1984","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.biopha.2017.10.107_bib0030","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1128\/AAC.24.5.815","article-title":"Effect of gentamicin treatment on adenylate cyclase and Na+, K+-ATPase activities in renal tissues of rats","volume":"24","author":"Queener","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2017.10.107_bib0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tox.2016.12.003","article-title":"A systematic meta-analysis on the efficacy of pre-clinically tested nephroprotectants at preventing aminoglycoside nephrotoxicity","volume":"377","author":"Vicente-Vicente","year":"2017","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.biopha.2017.10.107_bib0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1742-7843.2011.00728.x","article-title":"Experimental gentamicin nephrotoxicity and agents that modify it: a mini-review of recent research","volume":"109","author":"Ali","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.107_bib0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.numecd.2016.03.002","article-title":"DPP-4 inhibitors and cardiovascular disease in type 2 diabetes mellitus expectations, observations and perspectives","volume":"26","author":"Bonora","year":"2016","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.107_bib0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1517\/14740338.2015.977863","article-title":"DPP-4 inhibitors: focus on safety","volume":"14","author":"Tella","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.biopha.2017.10.107_bib0055","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jcjd.2014.05.001","article-title":"Blood pressure-lowering effects of incretin-based diabetes therapies","volume":"38","author":"Lovshin","year":"2014","journal-title":"Can. J. Diabetes"},{"issue":"3","key":"10.1016\/j.biopha.2017.10.107_bib0060","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3164\/jcbn.15-84","article-title":"Sitagliptin can inhibit the development of hepatic steatosis in high-fructose diet-fed ob\/ob mice","volume":"57","author":"Sujishi","year":"2015","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.biopha.2017.10.107_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13069-016-0038-0","article-title":"Dipeptidyl peptidase-4 and kidney fibrosis in diabetes","volume":"9","author":"Shi","year":"2016","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"8","key":"10.1016\/j.biopha.2017.10.107_bib0070","doi-asserted-by":"crossref","first-page":"F878","DOI":"10.1152\/ajprenal.00590.2014","article-title":"Anti-inflammatory role of DPP-4 inhibitors in a nondiabetic model of glomerular injury","volume":"308","author":"Higashijima","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.107_bib0075","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/ki.2014.236","article-title":"The potential for renoprotection with incretin-based drugs","volume":"86","author":"Tanaka","year":"2014","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.107_bib0080","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bbrc.2013.12.049","article-title":"Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes","volume":"443","author":"Kodera","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.107_bib0085","doi-asserted-by":"crossref","first-page":"956","DOI":"10.5114\/aoms.2017.68143","article-title":"Additive effects of atorvastatin combined with sitagliptin on rats with myocardial infarction: a pilot study","volume":"13","author":"Ke","year":"2017","journal-title":"Arch. Med. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.107_bib0090","doi-asserted-by":"crossref","first-page":"e0125285","DOI":"10.1371\/journal.pone.0125285","article-title":"Ameliorative effect of chrysin on adenine-induced chronic kidney disease in rats","volume":"10","author":"Ali","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2017.10.107_bib0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.vascn.2013.09.001","article-title":"Some physiological and histological aspects of the gastrointestinal tract in a mouse model of chronic renal failure","volume":"69","author":"Ali","year":"2014","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"2","key":"10.1016\/j.biopha.2017.10.107_bib0100","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ccc.2006.02.003","article-title":"Drug-associated renal dysfunction","volume":"22","author":"Taber","year":"2006","journal-title":"Crit. Care Clin."},{"issue":"12","key":"10.1016\/j.biopha.2017.10.107_bib0105","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/ki.2010.475","article-title":"Drug use and nephrotoxicity in the intensive care unit","volume":"81","author":"Perazella","year":"2012","journal-title":"Kidney Int."},{"issue":"suppl. 2","key":"10.1016\/j.biopha.2017.10.107_bib0110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1179\/acb.2007.077","article-title":"Acute kidney injury, length of stay, and costs in patients hospitalized in the intensive care unit","volume":"62","author":"Vandijck","year":"2007","journal-title":"Acta Clin. Belg."},{"issue":"7","key":"10.1016\/j.biopha.2017.10.107_bib0115","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/ndt\/gfu016","article-title":"The economic impact of acute kidney injury in England","volume":"29","author":"Kerr","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.biopha.2017.10.107_bib0120","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2215\/CJN.01430406","article-title":"Timing of initiation of dialysis in critically ill patients with acute kidney injury","volume":"1","author":"Liu","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.107_bib0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0378-4274(90)90067-V","article-title":"Pathogenic factors in aminoglycoside-induced nephrotoxicity","volume":"51","author":"Kacew","year":"1990","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.107_bib0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1681\/ASN.V4181","article-title":"Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy?","volume":"4","author":"Leehey","year":"1993","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.biopha.2017.10.107_bib0135","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/AAC.01430-08","article-title":"Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units","volume":"53","author":"Oliveira","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.107_bib0140","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1159\/000142935","article-title":"Antioxidants Do they have a place in the prevention or therapy of acute kidney injury?","volume":"109","author":"Koyner","year":"2008","journal-title":"Nephron Exp. Nephrol."},{"issue":"5","key":"10.1016\/j.biopha.2017.10.107_bib0145","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/0886022X.2016.1160207","article-title":"Sclerostin levels in uremic patients: a link between bone and vascular disease","volume":"38","author":"Bruzzese","year":"2016","journal-title":"Ren. Fail."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.107_bib0150","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/jphp.12534","article-title":"Alleviation of renal mitochondrial dysfunction and apoptosis underlies the protective effect of sitagliptin in gentamicin-induced nephrotoxicity","volume":"68","author":"Abuelezz","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.107_bib0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/aps.2014.98","article-title":"Sitagliptin protects rat kidneys from acute ischemia-reperfusion injury via upregulation of GLP-1 and GLP-1 receptors","volume":"36","author":"Chang","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2017.10.107_bib0160","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1479-5876-11-270","article-title":"Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction","volume":"11","author":"Chen","year":"2013","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.107_bib0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0742-8413(95)00075-5","article-title":"Comparison of gentamicin nephrotoxicity between rats and mice","volume":"112","author":"Suzuki","year":"1995","journal-title":"Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217313501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217313501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:31:53Z","timestamp":1780338713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217313501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":33,"alternative-id":["S0753332217313501"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.10.107","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on gentamicin nephrotoxicity in mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.10.107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}